RICHARD CORTEZ CAMARILLO

Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Gerontology BROWNSVILLE, TX NPI 1982476321

General Payments — all program years on this page

$529.76

  • Category: General Payments
  • Program years: PY2024
  • Record count: 22
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $529.76 across 22 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $529.7622

By paying entity

Latest program year (PY2024) · sorted by reported total.

Paying entityAmountRecords
ABBVIE INC. $214.6311
Acerta Pharma LLC $194.804
Novo Nordisk AS $35.882
PFIZER INC. $35.582
Lilly USA, LLC $29.892
MEDLINE INDUSTRIES LP $18.981

By program year

Program yearAmountRecords
2024 $529.7622

Records — PY2024 (22)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1100551462 Novo Nordisk Inc $16.90 10/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1100610748 Novo Nordisk Inc $18.98 03/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104292452 AstraZeneca Pharmaceuticals LP $18.29 12/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104518874 AstraZeneca Pharmaceuticals LP $145.20 02/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104752486 AstraZeneca Pharmaceuticals LP $17.42 10/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105805912 AstraZeneca Pharmaceuticals LP $13.89 12/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1106868339 ABBVIE INC. $10.70 04/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1106868341 ABBVIE INC. $95.61 04/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1106868343 ABBVIE INC. $10.52 05/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1106868345 ABBVIE INC. $8.43 05/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1106868347 ABBVIE INC. $19.18 05/31/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1106868349 ABBVIE INC. $3.42 07/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1106868351 ABBVIE INC. $12.74 08/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1106868353 ABBVIE INC. $17.31 08/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1106868355 ABBVIE INC. $18.31 09/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1106868357 ABBVIE INC. $5.21 10/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1106868359 ABBVIE INC. $13.20 10/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131867128 PFIZER INC. $22.18 08/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1132071837 PFIZER INC. $13.40 10/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135930156 Lilly USA, LLC $13.85 04/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135935130 Lilly USA, LLC $16.04 07/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1144138083 Medline Industries LP $18.98 05/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.